Bailard’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,600
Closed -$203K 703
2022
Q3
$203K Buy
+2,600
New +$208K 0.01% 600
2022
Q2
Sell
-3,900
Closed -$256K 680
2022
Q1
$256K Sell
3,900
-400
-9% -$23.2K 0.01% 599
2021
Q4
$261K Hold
4,300
0.01% 580
2021
Q3
$274K Buy
+4,300
New +$271K 0.01% 564

Other funds holding ACHC

Bailard's ACHC Position: Q4 2022 in Review

Bailard sold out of Acadia Healthcare (ACHC) in Q4 2022, closing a stake of 2,600 shares — an estimated $203K sold.

Bailard first reported a position in ACHC in Q3 2021 and held it in 4 quarters. The position peaked at $274K in Q3 2021. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.

  • Bailard reported no remaining Acadia Healthcare position as of Q4 2022 after selling out during the quarter.
  • Bailard sold 2,600 Acadia Healthcare shares in Q4 2022, an estimated $203K.
  • Bailard first reported a position in Acadia Healthcare in Q3 2021 and held it in 4 quarters.
  • Bailard's Acadia Healthcare position peaked at $274K in Q3 2021.
  • 346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.

Based on Bailard's 13F filing for Q4 2022, filed 2 Feb 2023.